Neuroprotective Therapy for Parkinson's Disease

Author： Koller W.C.  

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.144, Iss.1, 1997-03, pp. : 24-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurotoxicological and Neuroprotective Elements in Parkinson's Disease

By Kostrzewa Richard M.   Segura-Aguilar Juan  

Neurotoxicity Research, Vol. 4, Iss. 2, 2002-01 ,pp. : 83-86

Springer Publishing Company

Access to resources Recommend Favorite

Multifunctional neuroprotective–neurorescue drugs for Parkinson’s disease

By Van der Schyf Cornelis J   Geldenhuys Werner J   Youdim Moussa BH  

Future Neurology, Vol. 2, Iss. 4, 2007-07 ,pp. : 411-423

Future Medicine

Access to resources Recommend Favorite

Intravenous apomorphine therapy in Parkinson's disease

By Manson A.J.  

Brain, Vol. 124, Iss. 2, 2001-02 ,pp. : 331-340

Oxford University Press

Access to resources Recommend Favorite

Studies on Neuroprotective and Regenerative Effects of GDNF in a Partial Lesion Model of Parkinson's Disease

By Bjorklund A.   Rosenblad C.   Winkler C.   Kirik D.  

Neurobiology of Disease, Vol. 4, Iss. 3, 1997-03 ,pp. : 186-200

Academic Press

Access to resources Recommend Favorite

Might deep brain stimulation of the subthalamic nucleus be neuroprotective in patients with Parkinson's disease?

By Benabid A.L.   Piallat B.   Wallace B.   Benazzouz A.   Lenartz D.   Andressen C.   Krack P.   Pollak P.  

Thalamus & Related Systems, Vol. 2, Iss. 2, 2003-04 ,pp. : 95-102

Elsevier

Access to resources Recommend Favorite